Terbinafine has previously been shown to be highly active against dermatoph
ytes and many other filamentous fungi. However, its activity against yeasts
is controversial, with earlier reports suggesting that it has low activity
, while more recent studies demonstrated that terbinafine is effective agai
nst yeasts. In this study, the in vitro activity of terbinafine was evaluat
ed against a broad range of fungal isolates. We examined the susceptibility
of 100 yeast strains (10 species including Candida albicans, non-C. albica
ns, fluconazole-susceptible and -resistant candidal strains), and 184 strai
ns of filamentous fungi and dermatophytes (29 species including Aspergillus
, Fusarium, Sporothrix, Trichophyton rubrum, T. mentagrophytes, T. tonsuran
s, Microsporum canis and Epidermophyton floccosum), using the NCCLS M27-A m
icrodilution methodology for yeasts and a modified M38-P methodology for mo
ulds. The endpoint for terbinafine was defined as 80% inhibition compared w
ith the growth control well. The mean yeast and filamentous fungi minimum i
nhibitory concentration values +/- SEM (in mu g ml(-1)) for terbinafine wer
e: 6.60 +/- 0.73 and 1.04 +/- 0.28 respectively. In conclusion, our data su
ggest that terbinafine, in addition to its potent activity against dermatop
hytes, is considerably effective against a broad range of yeasts and filame
ntous fungi in vitro. Therefore, investigations concerning its antifungal a
ctivity in vivo against such organisms should be pursued.